The SLP76/LAT logic gate was validated using a commonly used xenograft model of acute lymphoblastic leukemia (NALM6) in NSG mice, where the tumor cells expressed ROR1 and CD19 antigens as dual targets. The gene discussed is CD19; the disease is neoplasm.